Skip to main content

New: AI Privacy Impact Assessments for teams shipping AI features. Learn about AI-PIAs

Pen testing · Digital health & life sciences

Penetration Testing for AI Scribe & Clinical AI Vendors

Penetration testing for an AI scribe or clinical AI vendor has to cover the model endpoint and the prompt path into it, not only the web application login screen. The trigger is usually a hospital AI procurement checklist asking for testing evidence beyond a standard vulnerability scan, or a program pre-qualification application that names security testing as a requirement. We scope the test to the ASR/LLM pipeline your buyers actually worry about.

Reviewed by the Privacy Horizon team · Last reviewed

What you're protecting

What a scribe vendor's penetration test has to reach

A test scoped only to the marketing site or the login flow misses where a clinical AI product actually carries risk.

The model endpoint itself

The API surface that accepts audio or text and returns a draft note, tested for how it handles malformed, oversized or adversarial input rather than assumed safe because a vendor manages it.

Prompt injection paths

Whether text embedded in EMR context, clinician free-text notes or the transcribed audio itself can alter model behaviour or leak instructions meant to stay internal.

Tenant boundaries in shared inference infrastructure

Whether one clinic's session, cache or context can be reached from another's, a risk unique to multi-tenant products built on shared LLM infrastructure.

EMR write-back integration points

Authentication and authorization on the connection that pushes a generated note into TELUS PS Suite, Med Access, QHR Accuro, OSCAR Pro, or hospital Epic and Oracle Health environments.

Mobile capture app and API

The clinician-facing app used to record consult audio, tested for local storage handling, transport security and session management on the device itself.

Regulatory map

Why testing evidence is now part of clinical AI procurement

Hospital and program reviewers ask for testing evidence specifically because the attack surface here differs from a conventional SaaS product.

Infoway and provincial program pre-qualification

The national AI Scribe Program pre-qualifies vendors partly on cybersecurity evidence, and independent testing results are the artifact reviewers can actually evaluate rather than a claim in a sales deck.

Primary source →

PHIPA's safeguard expectations for electronic service providers

An ESP handling PHI is expected to maintain reasonable technical safeguards, and a documented penetration test is standard evidence a custodian's own reviewer will ask to see.

Read our guide →

HIPAA's Security Rule risk analysis

US health-system buyers expect testing results to feed the documented risk analysis their own compliance program requires under the Security Rule.

Primary source →

OPC principles on adversarial testing

The OPC's generative AI principles name adversarial testing as a developer duty, giving Canadian regulators a stated expectation that model-layer testing, not just infrastructure testing, has occurred.

Primary source →

What goes wrong

What model-endpoint testing is designed to find

These are the failure modes standard infrastructure testing tends to miss on an AI scribe or clinical AI product.

  • Prompt injection distorting a clinical note

    Crafted input reaching the model through voice or EMR context that changes what the model writes into a document that becomes part of the legal medical record.

  • Cross-tenant data leakage

    Session, cache or context bleed between clinics sharing the same inference infrastructure, surfaced only by testing specifically designed around multi-tenant model architecture.

  • Authentication weaknesses on clinician accounts

    Credential stuffing or session-hijacking paths into accounts without multi-factor authentication, a pattern behind several large-scale consumer data compromises.

  • Insecure EMR write-back authorization

    A write-back connection that trusts the calling application rather than verifying the specific clinician and encounter, which could let a note attach to the wrong patient record.

Our pen testing for ai scribe & clinical ai vendors

What our penetration testing service covers for this niche

Vulnerability exploration, response observation and defensive guidance, re-cut to include the model endpoint alongside the standard application layers.

UX designer creative group working about planing mobile application project with sticky notes. User experience concept
  1. Web and mobile application testing

    Standard exploration of the clinician-facing app and any administrative portal for the vulnerabilities that affect any application handling sensitive data.

  2. Model-endpoint and prompt-injection testing

    Targeted testing of the ASR/LLM API surface for adversarial input handling, injection resistance and tenant isolation, matched to how hospital AI checklists now ask for this specifically.

  3. EMR integration testing

    Assessment of the authentication and data-handling on the connection that writes generated notes back into a customer's electronic medical record.

  4. Response capability observation

    General insight into how your environment reacts during simulated attack attempts, helping identify where detection and response controls need to be clearer or faster.

  5. Defensive improvement guidance

    Directional findings mapped to what a hospital procurement checklist or program pre-qualification review is likely to ask about, so remediation priorities match what buyers will actually see.

How the engagement runs

How penetration testing runs for a scribe or clinical AI vendor

Scoped around the audio and inference pipeline first, then the surrounding application layers.

  1. Step 1

    Scope the pipeline

    We map the path from audio capture through ASR, LLM inference and EMR write-back to define what a meaningful test has to cover.

  2. Step 2

    Test the application and endpoints

    We run controlled testing against the web and mobile application, the model endpoint, and the integration points identified in scoping.

  3. Step 3

    Observe response and detection

    We note how the environment reacts during testing, surfacing gaps in monitoring and alerting alongside the technical findings.

  4. Step 4

    Deliver findings and guidance

    You receive a clear report of what was found, its relative significance, and directional guidance on strengthening the areas that matter most to your buyers.

What it costs

What determines penetration testing cost for this niche

Cost tracks the number of components in scope: the web application, the mobile capture app, the number of EMR integrations, and whether model-endpoint and prompt-injection testing are included alongside standard application testing. A vendor with three EMR connectors and shared multi-tenant inference infrastructure needs a broader scope than one still serving a single clinic on a dedicated deployment.

We scope and quote after reviewing your architecture and the specific procurement checklist or program requirement driving the request, since a hospital review and an Infoway application don't always ask for identical evidence.

AI Scribe & Clinical AI Vendors: Pen testing questions, answered

Yes, and increasingly hospital reviewers expect it explicitly. A test limited to the web application and infrastructure layer misses the risk unique to an AI scribe: adversarial input reaching the model through voice or EMR context, and the possibility of cross-tenant leakage in shared inference infrastructure. We scope model-endpoint testing as a standard component for this niche, not an add-on.

Most checklists want a recent, independently conducted test report covering the application and, increasingly, the model layer, with findings tracked to remediation. A report that only covers the marketing site or a generic infrastructure scan will not satisfy a reviewer who has read the IPC's guidance and knows to ask about the inference pipeline specifically.

At minimum annually, plus after any material change to the model provider, a new EMR integration, or a significant architecture shift in the inference pipeline. Because model behaviour and prompt handling can change between provider updates, a scribe vendor's testing cadence should track its release calendar more closely than a typical SaaS company's.

Each new EMR write-back path is a new trust boundary and should be assessed as scope expands, though it doesn't always require a fully separate engagement. We typically fold new integrations into the next scheduled test or scope a targeted assessment if a major hospital deal is waiting on evidence for that specific connector.

A vulnerability scan checks known signatures against your infrastructure automatically; it will not exercise a prompt-injection path or test whether your multi-tenant inference setup actually isolates clinics from each other. Both have a place, but a hospital or program reviewer asking about AI-specific risk is asking for the deeper, manual testing a scan cannot perform.

What's Protecting Your Business from the Next Threat?

Don't wait for a breach to expose your vulnerabilities. Let Privacy Horizon secure your data, ensure compliance, and build lasting trust.

(647) 622-2644

Free, no obligation

Get a quote

Tell us what you need and we'll come back within one business day with a tailored quote.

We only use your details to respond to this request.